Abstract
Hypertension (HTN) has been demonstrated as one of the leading risk factors for development of cardiovascular disease (CVD) and CVD mortality. This study examines the prevalence and distribution of HTN subtypes (isolated diastolic hypertension [IDH], isolated systolic hypertension [ISH], and systolic-diastolic hypertension [SDH]) across age, sex, and race/ethnicity per the nationally representative National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018 based on the updated 2017 ACC/AHA HTN definition and their association with CVD and all-cause mortality. Among US adults, the overall prevalence of HTN is 41.1%. Across increasing age, the prevalence of IDH decreased, ISH increased, and SDH increased and peaked in the 6th decade of life after which SDH prevalence decreased. By age 80, over 80% of persons with HTN demonstrated ISH. A sub-cohort from NHANES 1999-2008 with follow-up until 2018 showed that ISH and SDH were most strongly associated with increased risk for CVD (HR 1.20 and 1.37, p<0.01, respectively) and all-cause mortality (HR 1.17 and 1.21, p<0.01, respectively). Our data demonstrate the continuing importance of HTN subtype transitions across age and their differences in predicting future CVD and total mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Support was provided by the Stanley S. Franklin MD Memorial Endowment Fund for Hypertension and Heart Disease Prevention Research from the University of California, Irvine.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval not required
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Authors’ Contributions: KST and JEJ contributed to writing, editing, and data analysis. NDW conceived of the project. NDW and WF contributed to editing and oversight. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.
Data Availability
NHANES data is publicly available online via the Centers for Disease Control and Prevention.
Non-standard Abbreviations and Acronyms
- ACC
- American College of Cardiology
- AHA
- American Heart Association
- BMI
- Body Mass Index
- BP
- Blood Pressure
- CI
- Confidence Interval
- CKD
- Chronic Kidney Disease
- CVD
- Cardiovascular Disease
- DALY
- Disability-Adjusted Life-Year
- DBP
- Diastolic Blood Pressure
- DM
- Diabetes Mellitus
- eGFR
- Estimated Glomerular Filtration Rate
- HR
- Hazard Ratio
- HTN
- Hypertension
- IDH
- Isolated Diastolic Hypertension
- ISH
- Isolated Systolic Hypertension
- NHANES
- National Health and Nutrition Examination Survey
- SBP
- Systolic Blood Pressure
- SDH
- Systolic-Diastolic Hypertension
